[Therapeutic use of an enriched insulin-glucose-heparin mixture in acute myocardial infarct].
Data on clinical efficiency of concentrated insulin-glucose-heparin mixture in 52 patients with acute myocardial infarction are presented. In the control group (19 patients) routine treatment was supplemented by heparin administration. The efficiency of the insulin-glucose-heparin mixture was assessed on the basis of general clinical data as well as radioimmuno-assays of plasma myoglobin patterns. The treated patients demonstrated a more favourable course of infarction, and manifest positive changes in their ECG parameters and blood transaminase activity. Myoglobinemia augmentation was inhibited within the first hours of myocardial infarction. It is suggested that the therapeutic mixture examined is conducive to limiting the area of myocardial lesion.
D001786:Blood Glucose / Q000032:analysis; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D009211:Myoglobin / Q000097:blood; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D009211:Myoglobin; D006493:Heparin; D005947:Glucose
Lechebnoe primenenie obogashchennoĭ insulino-gliukozo-geparinovoĭ smesi u bol'nykh ostrym infarktom miokarda.